AstraZeneca trials show antibody drug more than 80% effective at preventing COVID-19

COVID-19 vaccine maker AstraZeneca announced Thursday that its antibody drug is more than 80% effective at reducing risk of severe disease or death.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.